# Physician Clearance Documentation

**Date:** January 27, 2024  
**Study Week:** 4  
**Participant:** bob_001

---

## Summary

Participant cleared to continue study participation following Week 4 check-in.

## Vitals Review

| Metric                  | Value       | Status |
| ----------------------- | ----------- | ------ |
| Blood Pressure          | 124/78 mmHg | Normal |
| Resting Heart Rate      | 66 bpm      | Normal |
| Reported Adverse Events | None        | Pass   |

## Clinical Notes

No adverse health events reported or observed. Blood pressure readings within normal range throughout baseline and intervention phases. Participant reports no headaches, jitteriness, or sleep disturbances beyond normal variation.

Caffeine reduction appears well-tolerated. No contraindication to continued participation.

## Recommendation

**Continue study as planned.** No modifications required.

---

_Documentation generated from physician consultation, Week 4 of Desirable Difficulty study._